• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Heru partners with Vision Source on commercial availability of wearable diagnostic, VF app

Article

Heru Inc., announced Thursday that it has partnered with Vision Source on the commercial availability launch of re:Vive, a wearable diagnostics and visual field application.

re:ViveTM by Heru provides automated screening and full threshold exam strategies

re:ViveTM by Heru provides automated screening and full threshold exam strategies. (Image courtesy of Heru)


Heru Inc.
, announced Thursday that it has partnered with Vision Source in the commercial availability of re:Vive, a wearable diagnostics and visual field application.

Originally developed by Heru, re:Vive is a wearable portable solution that allows physicians to collect vital clinical data at any point during a patient’s visit—no additional testing space or designated dark room required, according to a company news release.

re:ViveTM by HeruTM provides automated screening and full threshold exam strategies

(Image courtesy of Heru)


The re:ImagineTM threshold algorithm adapts and predicts an optimized full-threshold testing workflow without compromising clinical performance, the company stated. Such results are comparable to the Humphrey perimeter.

With access to Vision Source's network of over 3,600 locally owned practices and 4,500 doctors, Heru CEO and founder Mohamed Abou Shousha, MD, PhD, said the company is helping to empower eye care physicians with breakthrough technology to provide better access to care for patients.

“We are thrilled to be Heru’s worldwide launch partner,” said John McCall, OD, Vision Source senior vice president, in a statement. “With their innovative technology and our network of independent optometrists, we have the potential to transform eye care.”

Compared to today's devices that limit a clinician’s ability to schedule patients for screening, re:Vive uses the company's AutoWorkflowTM to minimize time needed to detect disease and improve staff’s efficiency, according to the release.

The company also stated that it will be utilizing its patented active track system (ActiveTrackTM to analyze real-time gaze tracking and confirm a patient’s fixation is always appropriate, improving data quality while keeping the patient engaged and focused throughout an exam.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.